SciClone Pharmaceuticals (Holdings) Limited (HK:6600) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
SciClone Pharmaceuticals (Holdings) Limited announced the passing of key resolutions at their Annual General Meeting held on June 28, 2024, with overwhelming support for the adoption of audited financial statements and re-election of directors, alongside a special resolution to amend the company’s articles of association. However, resolutions to extend the mandate to issue additional shares faced opposition, with less than 50% approval. Shareholders also granted a mandate to repurchase shares and endorsed the reappointment of PricewaterhouseCoopers as the auditor.
For further insights into HK:6600 stock, check out TipRanks’ Stock Analysis page.